If approved, TLX250-CDx will become the first commercially available imaging agent to accurately and non-invasively diagnose and characterize clear cell renal cell carcinoma (ccRCC), the most common ...

A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...

By Sen. Tracy Pennycuick 24th District I heard it said recently that it’s great politics to be all things to all people.

The FDA granted priority review to pembrolizumab for neoadjuvant and adjuvant use in head and neck squamous cell carcinoma, ...

It won’t happen until after the quarterback position is resolved. It might not transpire until late in training camp or a few ...

ZenBusiness is a business formation service that will help you file the paperwork for registering a business entity as either ...

Discover everything you need to know about Ruby Slots sister casinos, including exclusive bonuses, games, payments, and ...

The $149 Satechi 6-Port Charging Station can output 200W over multiple USB-C ports, although not as intelligently as the ...

Precigen on Tuesday said a green light would make PRGN-2012 the only FDA-approved therapeutic for the treatment of adults with the disorder, which is a lifelong neoplastic disease of the upper and ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.

Merck (MRK) announced the FDA has accepted for priority review a new supplemental Biologics License Application seeking approval for keytruda – ...

Going out to eat? See which Alachua County restaurants were rated best by inspectors, and which failed the test.